This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Tracey A Rouault: Innovator in Nitroxide Therapy
Introduction
Tracey A Rouault is a prominent inventor based in North Bethesda, MD (US). She has made significant contributions to the field of medical therapy, particularly in the treatment of von Hippel–Lindau disease (VHL) and renal clear cell carcinoma (RCC). Her innovative approach focuses on the use of stable nitroxides to address conditions associated with reduced VHL or elevated HIF-2α.
Latest Patents
Tracey A Rouault holds a patent for her invention titled "Nitroxide therapy for the treatment of von Hippel–Lindau disease (VHL) and renal clear cell carcinoma (RCC)." This patent outlines therapeutic methods that involve administering a stable nitroxide to subjects who have, are suspected to have, or are at risk for conditions related to VHL.
Career Highlights
Rouault works for the United States of America, as represented by the Secretary, Department of Health and Human Services. Her career is marked by a commitment to advancing medical therapies that can significantly improve patient outcomes.
Collaborations
Throughout her career, Tracey has collaborated with notable colleagues, including W Marston Linehan and James B Mitchell. These partnerships have contributed to her research and the development of her innovative therapies.
Conclusion
Tracey A Rouault is a dedicated inventor whose work in nitroxide therapy represents a significant advancement in the treatment of serious medical conditions. Her contributions continue to impact the field of medical research and therapy.